FWD Group marks 13 years with charitable grants benefitting over 13,000 people across Asia 
Kincora Reports June 2026 Quarterly Activities and Financial Results 
CALB Announces Positive Profit Alert 
uSMART Launches ’12-Fee Waiver’ Promotion for Silver Bonds 
Analysts See SHEIN at US$35-40bn Ahead of IPO, Citing Global Fashion Scale and Strong Financials Vaccinex to Present Update on PDAC/Pepinemab Study; New ActivMAb® Application
Phase 1b/2 pepinemab/PDAC study update to be presented on September 29 at special AACR meeting…
SciSparc Announces Expected Implementation of 1-for-26 Reverse Share Split
Following the reverse share split, the Company will have approximately 521,090 Ordinary Shares issued and…
SciSparc Announces Expected Implementation of 1-for-26 Reverse Share Split
Following the reverse share split, the Company will have approximately 521,090 Ordinary Shares issued and…
PharmaTher Announces FDA Acceptance, As a Priority Original Abbreviated New Drug Application, for KETARX™ (Ketamine)
FDA assigns GDUFA goal date of April 29, 2024 Milestone builds upon PharmaTher’s commitment toward…
PharmaTher Announces FDA Acceptance, As a Priority Original Abbreviated New Drug Application, for KETARX™ (Ketamine)
FDA assigns GDUFA goal date of April 29, 2024 Milestone builds upon PharmaTher’s commitment toward…
Sensei Biotherapeutics Announces Initiation of Combination Arm for Phase 1/2 Clinical Study of SNS-101 with Regeneron’s Libtayo®
– Eleven patients enrolled overall in trial to date, with enrollment progressing faster than anticipated…
Sensei Biotherapeutics Announces Initiation of Combination Arm for Phase 1/2 Clinical Study of SNS-101 with Regeneron’s Libtayo®
– Eleven patients enrolled overall in trial to date, with enrollment progressing faster than anticipated…
Matinas BioPharma to Feature MAT2203 in a Pipeline Presentation at IDWeek
BEDMINSTER, N.J., Sept. 27, 2023 (GLOBE NEWSWIRE) — Matinas BioPharma (NYSE American: MTNB), a clinical-stage…
Matinas BioPharma to Feature MAT2203 in a Pipeline Presentation at IDWeek
BEDMINSTER, N.J., Sept. 27, 2023 (GLOBE NEWSWIRE) — Matinas BioPharma (NYSE American: MTNB), a clinical-stage…
UNITY Biotechnology Announces 48-Week Results from Phase 2 ENVISION Study of UBX1325 in Patients with Wet Age-Related Macular Degeneration
Patients on combination treatment with UBX1325 and aflibercept from weeks 24-48 maintained vision gains achieved…
UNITY Biotechnology Announces 48-Week Results from Phase 2 ENVISION Study of UBX1325 in Patients with Wet Age-Related Macular Degeneration
Patients on combination treatment with UBX1325 and aflibercept from weeks 24-48 maintained vision gains achieved…
Forcefield Therapeutics appoints John Tsai MD as Chief Executive Officer
John will lead the company as CEO to explore the potential of a novel therapeutic…
Forcefield Therapeutics appoints John Tsai MD as Chief Executive Officer
John will lead the company as CEO to explore the potential of a novel therapeutic…
ProQR Therapeutics Provides Update on Ophthalmic Assets
LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 27, 2023 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:…
ProQR Therapeutics Provides Update on Ophthalmic Assets
LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 27, 2023 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:…
Avalyn Raises $175 Million in Oversubscribed Series C Financing to Advance Inhaled Pulmonary Fibrosis Programs into Later Stage Clinical Studies
Financing led by Perceptive Xontogeny Venture Funds, SR One, and Eventide Asset Management, with participation…
Avalyn Raises $175 Million in Oversubscribed Series C Financing to Advance Inhaled Pulmonary Fibrosis Programs into Later Stage Clinical Studies
Financing led by Perceptive Xontogeny Venture Funds, SR One, and Eventide Asset Management, with participation…
Blue Mantis Named Official IT Services and Distribution Partner of Gillette Stadium and the New England Patriots
PORTSMOUTH, N.H., Sept. 27, 2023 (GLOBE NEWSWIRE) — Blue Mantis and Kraft Sports + Entertainment,…
Blue Mantis Named Official IT Services and Distribution Partner of Gillette Stadium and the New England Patriots
PORTSMOUTH, N.H., Sept. 27, 2023 (GLOBE NEWSWIRE) — Blue Mantis and Kraft Sports + Entertainment,…
Solo.io Launches Gloo Partner Network to Accelerate Cloud-Native Adoption at Scale
Partner Program Brings Together Global Experts to Lead the Industry Into a Cloud-Native Future CAMBRIDGE,…